Effect of the Frequency of Self-Monitoring Blood Glucose in Patients with Type 2 Diabetes Treated with Oral Antidiabetic Drugs—A Multi-Centre, Randomized Controlled Trial

Werner A. Scherbaum, Christian Ohmann, Heinz-Harald Abholz et al. · 2008

Read Effect of the Frequency of Self-Monitoring Blood Glucose in Patients with Type 2 Diabetes Treated with Oral Antidiabetic Drugs—A Multi-Centre, Randomized Controlled Trial by Werner A. Scherbaum, Christian Ohmann, Heinz-Harald Abholz et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003087.txt.

Description

Werner Scherbaum, Christian Ohmann, Heinz-Harald Abholz and co-authors randomized blood glucose self-monitoring schedules in type 2 diabetes in 2008. Advice on how often to self-monitor varies widely among physicians treating the disease. The trial enrolled patients with stable metabolic control on oral drugs.

Two testing regimens were compared in a multi-centre randomized controlled trial. Published in PLOS ONE, the design gives the frequency question a direct experimental answer. Finger-stick testing costs money and comfort, so knowing the useful frequency helps patients and health systems alike. The complete article sets out the methods and data behind each claim in full.

Catalog record

CREATORWerner A. Scherbaum, Christian Ohmann, Heinz-Harald Abholz et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003087

Browse the full library · About the Tower of Babel